Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: hematology-oncology-pharmacy-association.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
21 filings
$760K on those filings
Food Industry (safety, labeling, etc.)
FOO
6 filings
$180K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
118th Congress
Cancer Drug Parity Act of 2023
8 filingsthrough 2024
H.R. 1730116th CongressCancer Drug Parity Act of 20198 filingsthrough 2020
H.R. 2739114th CongressCancer Drug Coverage Parity Act of 20157 filingsthrough 2016
S. 1566114th CongressCancer Drug Coverage Parity Act of 20157 filingsthrough 2016
H.R. 1801113th CongressCancer Drug Coverage Parity Act of 20137 filingsthrough 2014
H.R. 2759117th CongressPharmacy and Medically Underserved Areas Enhancement Act6 filingsthrough 2022
H.R. 4385117th CongressCancer Drug Parity Act of 20216 filingsthrough 2022
H.R. 1409115th CongressCancer Drug Parity Act of 20176 filingsthrough 2018
S. 314114th CongressPharmacy and Medically Underserved Areas Enhancement Act6 filingsthrough 2016
H.R. 5376117th CongressAn act to provide for reconciliation pursuant to title II of S. Con. Res. 14.5 filingsthrough 2022
H.R. 3116th CongressElijah E. Cummings Lower Drug Costs Now Act5 filingsthrough 2020
H.R. 592115th CongressPharmacy and Medically Underserved Areas Enhancement Act5 filingsthrough 2018
S. 109115th CongressPharmacy and Medically Underserved Areas Enhancement Act5 filingsthrough 2018
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Jeremy ScottPowers Pyles Sutter & Verville, P.C.8 filingsthrough 2021
Sarah T. MillsFaegre Drinker Biddle & Reath LLPCovered position: Legislative Aide to US Senate Committee on Judiciary, office of the Ranking Member; Special Legislative Aide to US Senate Committee on Judiciary7 filingsthrough 2019
Anna Schwamlein HowardFaegre Drinker Biddle & Reath LLP4 filingsthrough 2014
Zachary KiserCavarocchi Ruscio Dennis Associates, L.L.C.3 filingsthrough 2021
Kelsi PutnamCavarocchi Ruscio Dennis Associates, L.L.C.2 filingsthrough 2026
Nina BoyleCavarocchi Ruscio Dennis Associates, L.L.C.2 filingsthrough 2025
Hermela MebrahtuCavarocchi Ruscio Dennis Associates, L.L.C.2 filingsthrough 2023
Jim TwaddellFaegre Drinker Biddle & Reath LLPCovered position: Leg. Aide & Dep. Comm. Dir., Sen. Arlen Specter2 filingsthrough 2014
Stefani RinehartCavarocchi Ruscio Dennis Associates, L.L.C.1 filingthrough 2026
Joseph NahraPowers Pyles Sutter & Verville, P.C.1 filingthrough 2021
Phil GingreyFaegre Drinker Biddle & Reath LLPCovered position: Former United States Congressman 11th District of Georgia1 filingthrough 2019
Covered positions · 6 of 16 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
